View in EDS HTML Full Text PDF Full Text

Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies of advanced HCC with lower survival in non-viral patients.

Saved in:
Bibliographic Details
Title: Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies of advanced HCC with lower survival in non-viral patients.
Authors: Barakat, Eman M. F.1 (AUTHOR), Kohla, Mohamed2 (AUTHOR), Dabees, Hossam3 (AUTHOR), Shousha, Hend Ibrahim4 (AUTHOR) hendshousha@kasralainy.edu.eg, Moustafa, Ehab F.5 (AUTHOR), El-Kassas, Mohamed6 (AUTHOR), Aziz, Mona Shoukry3 (AUTHOR), Elkhateeb, Eman2 (AUTHOR), Abdelaziz, Ashraf Omar4 (AUTHOR), Abdelmalek, Mohamed Omar5 (AUTHOR), Azmy, Aly7 (AUTHOR), Tawheed, Ahmed6 (AUTHOR), Aboganob, Walaa Mosaad3 (AUTHOR), Taha, Hossam2 (AUTHOR), Lithy, Rania4 (AUTHOR), Radwan, Ahmed5 (AUTHOR), Ghoraba, Dalia1 (AUTHOR), Sayed, Hamdy6 (AUTHOR), Nassief, Anwar3 (AUTHOR), Elhelbawy, Mostafa2 (AUTHOR)
Source: Scientific Reports. 6/27/2025, Vol. 15 Issue 1, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-025-05828-x